Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Acceptability of Intanza® 15 μg intradermal influenza vaccine in Belgium during the 2010-2011 influenza season.

Dhont PA, Albert A, Brenders P, Podwapinska A, Pollet A, Scheveneels D, Tihon F, Verheyden I, Victor J, Samson SI.

Adv Ther. 2012 Jun;29(6):562-77. doi: 10.1007/s12325-012-0025-9. Epub 2012 Jun 1.

PMID:
22678831
2.

Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults.

Ansaldi F, de Florentiis D, Durando P, Icardi G.

Expert Rev Vaccines. 2012 Jan;11(1):17-25. doi: 10.1586/erv.11.154. Review.

PMID:
22149703
3.

Intanza(®): a new intradermal vaccine for seasonal influenza.

Atmar RL, Patel SM, Keitel WA.

Expert Rev Vaccines. 2010 Dec;9(12):1399-409. doi: 10.1586/erv.10.134. Review.

PMID:
21105776
4.

Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.

Leroux-Roels I, Weber F.

Hum Vaccin Immunother. 2013 Jan;9(1):115-21. doi: 10.4161/hv.22342. Review.

5.

A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events.

Marra F, Young F, Richardson K, Marra CA.

Influenza Other Respir Viruses. 2013 Jul;7(4):584-603. doi: 10.1111/irv.12000. Epub 2012 Sep 13. Review.

6.
7.

A systematic review of intradermal influenza vaccines.

Young F, Marra F.

Vaccine. 2011 Nov 8;29(48):8788-801. doi: 10.1016/j.vaccine.2011.09.077. Epub 2011 Oct 1. Review.

PMID:
21968444
8.

Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement.

Ansaldi F, Durando P, Icardi G.

Expert Opin Biol Ther. 2011 Mar;11(3):415-27. doi: 10.1517/14712598.2011.557658. Review.

PMID:
21299438
9.

Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future.

Levin Y, Kochba E, Hung I, Kenney R.

Hum Vaccin Immunother. 2015;11(4):991-7. doi: 10.1080/21645515.2015.1010871. Review.

Supplemental Content

Support Center